Cornerstone Investment Partners, LLC

Position in CRL — Charles River Laboratories International, Inc.

CIK 1328062 ATLANTA, GA

Position in CRL

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$619,965

-$80,209 QoQ

Shares Held

3,594

+2.4% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 92% Shared 0% None 8%

Healthcare · as of Mar 31, 2026

Cornerstone Investment Partners, LLC holds $120,688,418 across 6 Diagnostics & Research names. CRL ranks #3 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IQV	Iqvia Holdings Inc.	433,478	$73,925,338
2	TMO	Thermo Fisher Scientific Inc.	92,313	$45,374,608
3	CRL	Charles River Laboratories International, Inc. This page	3,594	$619,965
4	BLLN	BillionToOne, Inc.	3,402	$268,553
5	VCYT	Veracyte, Inc.	8,043	$259,065
6	WGS	GeneDx Holdings Corp.	3,751	$240,889

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$619,965	3,594	+2.4%	Shares	Sole	2026-05-08
2025-12-31	$700,174	3,510	+24.4%	Shares	Sole	2026-01-29
2025-09-30	$441,530	2,822	+37.3%	Shares	Sole	2025-11-06
2025-06-30	$311,805	2,055	+6.3%	Shares	Sole	2025-08-06
2025-03-31	$291,105	1,934	-0.3%	Shares	Sole	2025-04-30
2024-12-31	$358,124	1,940	+3.7%	Shares	Sole	2025-02-06
2024-09-30	$368,530	1,871	+0.1%	Shares	Sole	2024-11-13
2024-06-30	$386,098	1,869	+33.8%	Shares	Sole	2024-08-12
2024-03-31	$378,517	1,397	+1.8%	Shares	Sole	2024-04-29
2023-12-31	$324,340	1,372	—	Shares	Sole	2024-01-31
No filing history on record for this holder in this stock.